190 related articles for article (PubMed ID: 15661876)
1. Enhanced production of IL-10 by dendritic cells deficient in CIITA.
Yee CS; Yao Y; Xu Q; McCarthy B; Sun-Lin D; Tone M; Waldmann H; Chang CH
J Immunol; 2005 Feb; 174(3):1222-9. PubMed ID: 15661876
[TBL] [Abstract][Full Text] [Related]
2. Tumor-mediated down-regulation of MHC class II in DC development is attributable to the epigenetic control of the CIITA type I promoter.
Choi YE; Yu HN; Yoon CH; Bae YS
Eur J Immunol; 2009 Mar; 39(3):858-68. PubMed ID: 19224634
[TBL] [Abstract][Full Text] [Related]
3. Reduced IL-4-, lipopolysaccharide-, and IFN-gamma-induced MHC class II expression in mice lacking class II transactivator due to targeted deletion of the GTP-binding domain.
Itoh-Lindstrom Y; Piskurich JF; Felix NJ; Wang Y; Brickey WJ; Platt JL; Koller BH; Ting JP
J Immunol; 1999 Sep; 163(5):2425-31. PubMed ID: 10452977
[TBL] [Abstract][Full Text] [Related]
4. Critical role of the tumor suppressor tuberous sclerosis complex 1 in dendritic cell activation of CD4 T cells by promoting MHC class II expression via IRF4 and CIITA.
Pan H; O'Brien TF; Wright G; Yang J; Shin J; Wright KL; Zhong XP
J Immunol; 2013 Jul; 191(2):699-707. PubMed ID: 23776173
[TBL] [Abstract][Full Text] [Related]
5. ERK and p38 MAPK signaling pathways negatively regulate CIITA gene expression in dendritic cells and macrophages.
Yao Y; Xu Q; Kwon MJ; Matta R; Liu Y; Hong SC; Chang CH
J Immunol; 2006 Jul; 177(1):70-6. PubMed ID: 16785500
[TBL] [Abstract][Full Text] [Related]
6. Role of PU.1 in MHC class II expression through transcriptional regulation of class II transactivator pI in dendritic cells.
Kitamura N; Yokoyama H; Yashiro T; Nakano N; Nishiyama M; Kanada S; Fukai T; Hara M; Ikeda S; Ogawa H; Okumura K; Nishiyama C
J Allergy Clin Immunol; 2012 Mar; 129(3):814-824.e6. PubMed ID: 22112519
[TBL] [Abstract][Full Text] [Related]
7. Altered Th1 cell differentiation programming by CIITA deficiency.
Patel DR; Kaplan MH; Chang CH
J Immunol; 2004 Nov; 173(9):5501-8. PubMed ID: 15494498
[TBL] [Abstract][Full Text] [Related]
8. IL-12/IL-18-dependent IFN-gamma release by murine dendritic cells.
Stober D; Schirmbeck R; Reimann J
J Immunol; 2001 Jul; 167(2):957-65. PubMed ID: 11441104
[TBL] [Abstract][Full Text] [Related]
9. CpG DNA induces a class II transactivator-independent increase in class II MHC by stabilizing class II MHC mRNA in B lymphocytes.
Kuchtey J; Pennini M; Pai RK; Harding CV
J Immunol; 2003 Sep; 171(5):2320-5. PubMed ID: 12928377
[TBL] [Abstract][Full Text] [Related]
10. Class II transactivator-mediated regulation of major histocompatibility complex class II antigen expression is important for hematopoietic progenitor cell suppression by chemokines and iron-binding proteins.
Broxmeyer HE; Cooper S; Hangoc G; Chang CH
Exp Hematol; 2006 Aug; 34(8):1078-84. PubMed ID: 16863914
[TBL] [Abstract][Full Text] [Related]
11. Regulation of the class II MHC pathway in primary human monocytes by granulocyte-macrophage colony-stimulating factor.
Hornell TM; Beresford GW; Bushey A; Boss JM; Mellins ED
J Immunol; 2003 Sep; 171(5):2374-83. PubMed ID: 12928384
[TBL] [Abstract][Full Text] [Related]
12. The role of the MHC class II transactivator in class II expression and antigen presentation by astrocytes and in susceptibility to central nervous system autoimmune disease.
Stüve O; Youssef S; Slavin AJ; King CL; Patarroyo JC; Hirschberg DL; Brickey WJ; Soos JM; Piskurich JF; Chapman HA; Zamvil SS
J Immunol; 2002 Dec; 169(12):6720-32. PubMed ID: 12471103
[TBL] [Abstract][Full Text] [Related]
13. Bacterial DNA and immunostimulatory CpG oligonucleotides trigger maturation and activation of murine dendritic cells.
Sparwasser T; Koch ES; Vabulas RM; Heeg K; Lipford GB; Ellwart JW; Wagner H
Eur J Immunol; 1998 Jun; 28(6):2045-54. PubMed ID: 9645386
[TBL] [Abstract][Full Text] [Related]
14. CpG DNA induces maturation of dendritic cells with distinct effects on nascent and recycling MHC-II antigen-processing mechanisms.
Askew D; Chu RS; Krieg AM; Harding CV
J Immunol; 2000 Dec; 165(12):6889-95. PubMed ID: 11120813
[TBL] [Abstract][Full Text] [Related]
15.
Letendre C; Auger JP; Lemire P; Galbas T; Gottschalk M; Thibodeau J; Segura M
Front Immunol; 2018; 9():1199. PubMed ID: 29899744
[No Abstract] [Full Text] [Related]
16. MHC class II transactivator is an in vivo regulator of osteoclast differentiation and bone homeostasis co-opted from adaptive immunity.
Benasciutti E; Mariani E; Oliva L; Scolari M; Perilli E; Barras E; Milan E; Orfanelli U; Fazzalari NL; Campana L; Capobianco A; Otten L; Particelli F; Acha-Orbea H; Baruffaldi F; Faccio R; Sitia R; Reith W; Cenci S
J Bone Miner Res; 2014 Feb; 29(2):290-303. PubMed ID: 24038328
[TBL] [Abstract][Full Text] [Related]
17. Role of PU.1 in MHC Class II Expression via CIITA Transcription in Plasmacytoid Dendritic Cells.
Miura R; Kasakura K; Nakano N; Hara M; Maeda K; Okumura K; Ogawa H; Yashiro T; Nishiyama C
PLoS One; 2016; 11(4):e0154094. PubMed ID: 27105023
[TBL] [Abstract][Full Text] [Related]
18. Saturated and polyunsaturated fatty acids reciprocally modulate dendritic cell functions mediated through TLR4.
Weatherill AR; Lee JY; Zhao L; Lemay DG; Youn HS; Hwang DH
J Immunol; 2005 May; 174(9):5390-7. PubMed ID: 15843537
[TBL] [Abstract][Full Text] [Related]
19. Exosomes from CIITA-transfected CT26 cells enhance anti- tumor effects.
Fan W; Tian XD; Huang E; Zhang JJ
Asian Pac J Cancer Prev; 2013; 14(2):987-91. PubMed ID: 23621273
[TBL] [Abstract][Full Text] [Related]
20. Dendritic cells process and present antigens across a range of maturation states.
Veeraswamy RK; Cella M; Colonna M; Unanue ER
J Immunol; 2003 Jun; 170(11):5367-72. PubMed ID: 12759410
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
